Vladimir Tolmachev

88PUBLICATIONS
76CO-AUTHORS
Molecular targetsMedical devicesPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (88)

|Sep 07, 2026
Integrating Tumor Targeting and Half-Life Extension into a Dual-Surfaced Single-Domain ADAPT Protein.

|Aug 27, 2026
Evaluation of Site-Specific Radioiodination of Anti-EGFR-Targeted DARPin E01 Using (4-Hydroxyphenyl)ethyl Maleimide.

|Jul 31, 2026
Imaging of ROR1 expression in tumors using radiolabeled affibody molecules.

|Mar 04, 2026
The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99mTc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1.

Sergey Deyev, Anastasia Fominykh, Ruslan Varvashenya

|Feb 27, 2026
Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model.

Vladimir Tolmachev, Amelinda Janice Herlina, Eleftherios Papalanis

|Nov 13, 2025
Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors.

Mariia Larkina, Gleb Yanovich, Lutfi Aditya Hasnowo

Pageof 15

Frequent Collaborators

72 joint publications

Anna Orlova

39 joint publications

Anzhelika Vorobyeva

19 joint publications

Tianqi Xu

16 joint publications

Maryam Oroujeni